Loading clinical trials...
Loading clinical trials...
A Single-Dose, Double-Blind, Placebo-Controlled, Randomized, Crossover Study to Determine the Abuse Potential of Single Oral Dose of Seltorexant Compared To Suvorexant and Zolpidem
Conditions
Interventions
Suvorexant
Zolpidem
+2 more
Locations
1
United States
Altasciences Inc.
Overland Park, Kansas, United States
Start Date
December 17, 2021
Primary Completion Date
May 12, 2023
Completion Date
May 12, 2023
Last Updated
April 27, 2025
NCT04570436
NCT03200080
NCT01987739
Lead Sponsor
Janssen Research & Development, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions